newsfilter
← Latest News
PR Newswire·

EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and EMS, one of Brazil's leading pharmaceutical...